clearn.png
Thursday August 11th, 2022 5:12AM

Pfizer profit soars in first quarter, revises 2022 forecast

By The Associated Press
Related Articles
  Contact Editor

COVID-19 vaccine and treatment sales helped Pfizer breeze past Wall Street's first-quarter expectations, as the drugmaker's profit grew 61%.

The coronavirus vaccine Comirnaty brought in more than $13 billion in sales in the quarter, and the company is still trying to expand the market for the preventive shots.

Pfizer leaders said Tuesday they expect to submit to regulators by early June data on the effectiveness of a smaller, three-shot combination of their vaccine in children under age 5.

Currently, only children ages 5 or older can be vaccinated in the U.S. with Pfizer’s vaccine.

The pill treatment Paxlovid, which launched late last year, added another $1.5 billion in the first quarter.

All that helped company revenue swell 77%, compared to last year's quarter, when vaccine sales were still ramping up.

Overall, Pfizer on Tuesday posted net income of $7.86 billion and adjusted earnings of $1.62 per share in the first quarter.

That easily topped the $1.49 per share projected by industry analysts, according to a survey by FactSet.

Revenue was $25.66 billion, also beating Wall Street expectations for $24.1 billion.

Pfizer's COVID-19 vaccine launched in late 2020 and became the drugmaker’s top selling product by last year’s second quarter.

Pfizer books the vast majority of revenue from Comirnaty and splits profit, as well as the cost to make and distribute the vaccine, with development partner BioNTech.

Sales of that vaccine topped analyst expectations for the quarter, but revenue from Paxlovid fell short.

However, sales of the treatment are expected to pick up later this year, and President Joe Biden's administration is pushing to expand access to Paxlovid.

“We are seeing strong signs for increasing demand for Paxlovid,” Chairman and CEO Albert Bourla told analysts Tuesday.

He added that Pfizer booked only a small portion of revenue in the first quarter from the roughly 6 million doses it has shipped so far. He noted that international sales will be booked in the second quarter.

Revenue from both products will likely wind up exceeding forecasts, Mizuho Securities USA analyst Dr. Vamil Divan said in a research note. He noted that current projections only include contracts the company signed as of mid April.

During a Tuesday conference call to discuss the quarter, another analyst asked Pfizer executives about reports of COVID-19 recurring in patients after they have completed a Paxlovid treatment course.

Company officials said early data from outside clinical trials shows that these recurrences have been reported in less than 1 in 3,000 patients. They noted that patients with compromised immune systems can carry the virus for long periods of time, and Pfizer will study whether extended treatment courses may be appropriate in some cases.

Pfizer on Tuesday also revised the 2022 earnings forecast it debuted in February to reflect an accounting policy change. It now expects adjusted earnings of $6.25 to $6.45 per share.

That's down a dime on both ends of the range from its previous forecast for $6.35 to $6.55 per share.

Analysts forecast earnings of $7.14 per share.

Shares of Pfizer Inc., based in New York, climbed nearly 2% to $49.19 Tuesday.

Pfizer’s stock hit an all-time high price of $61.71 on Dec. 20. But that price has fallen 18% so far this year, a steeper drop than the roughly 13% decline of the Standard & Poor’s 500 index.

___

AP Medical Writer Lauran Neergaard contributed to this report.

___

Follow Tom Murphy on Twitter at @thpmurphy

  • Associated Categories: Associated Press (AP), AP Business, AP Business - Corporate News, AP Business - Industries, AP Business - Health Care
© Copyright 2022 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Live updates | Russia resumes strikes on Azovstal steelworks
The Russian military says they have resumed strikes on the Azovstal steel plant in the port city of Mariupol
8:26AM ( 8 minutes ago )
Wall Street points lower ahead of Fed meeting
U.S. markets pointed toward losses before markets opened on Tuesday as investors awaited a decision by the Federal Reserve on interest rates
8:19AM ( 15 minutes ago )
Pfizer profit soars in first quarter, revises 2022 forecast
Sales of Pfizer’s COVID-19 vaccine and treatment pushed the drugmaker well past expectations in the first quarter, as profit grew 61%
8:12AM ( 22 minutes ago )
Associated Press (AP)
Live updates | Slovakia to seek exemption from oil embargo
Slovakia’s energy minister says the country is not ready to join a European Union embargo on imports of Russian oil as part of a new package of sanctions to be imposed on Russia for its invasion of Ukraine
7:14AM ( 1 hour ago )
Pfizer tops Q1 expectations, revises 2022 forecast
Sales of Pfizer’s COVID-19 vaccine and treatment pushed the drugmaker well past expectations in the first quarter, as profit grew 61%
7:07AM ( 1 hour ago )
Aid workers prep stretchers, toys for Mariupol evacuees
Aid workers prepared hot food, wheelchairs and toys for civilians slowly making their way to relative safety from the pulverized remnants of a steel plant in the city of Mariupol
6:41AM ( 1 hour ago )
AP Business
Heat wave sparks blackouts, questions on India's coal usage
An unusually early and brutal heat wave is scorching parts of India, where acute power shortages are affecting millions as demand for electricity surges to record levels
2:47AM ( 5 hours ago )
Energy chief Granholm touts $3B plan to boost EV batteries
The Biden administration has announced $3.1 billion in funding to U.S. companies that make and recycle lithium-ion batteries
6:21PM ( 14 hours ago )
1,000 CNH Industrial workers strike in Iowa, Wisconsin
More than 1,000 workers at CNH Industrial plants in Wisconsin and Iowa have walked out on strike in search of a better deal with the company that makes agriculture and construction equipment
5:32PM ( 15 hours ago )
AP Business - Corporate News
Australian central bank hikes rate for 1st time in 11 years
Australia’s central bank has lifted its benchmark interest rate for the first time in more than 11 years
2:19AM ( 6 hours ago )
Australian central bank decides first rate hike in 11 years
Australia’s central bank has lifted its benchmark interest rate for the first time in more than 11 years
1:31AM ( 7 hours ago )
Asian shares mixed as Australia hikes interest rate
Asian shares are mixed after Australia's central bank raised a key interest rate for the first time since 2010
1:31AM ( 7 hours ago )
AP Business - Industries
Mower, co-inventor of implantable defibrillator, dies at 89
A cardiologist who helped invent an automatic implantable defibrillator that has helped countless heart patients live longer and healthier has died
6:25PM ( 1 day ago )
Q&A: Direct Relief CEO Thomas Tighe on how to help Ukraine
Helping Ukrainians can generally be done by using existing aid strategies
9:00AM ( 3 days ago )
Court says UK's nursing home COVID-19 policy was illegal
A British court has ruled that the Conservative government acted illegally when it discharged hospital patients into nursing homes without testing them for COVID-19 or isolating them
10:42AM ( 5 days ago )
AP Business - Health Care
Wall Street points lower ahead of Fed meeting
U.S. markets pointed toward losses before markets opened on Tuesday as investors awaited a decision by the Federal Reserve on interest rates
8:19AM ( 15 minutes ago )
German opposition leader visits Kyiv, Scholz refuses to go
Germany’s conservative opposition leader is in Kyiv for meetings with Ukrainian officials
8:05AM ( 30 minutes ago )
Strong BP profit renews call for energy sector windfall tax
BP posted its highest quarterly profit in more than a decade thanks to surging oil and gas prices
7:56AM ( 38 minutes ago )
Live updates | Test of far right power in Ohio governor race
Ohio Republican Gov. Mike DeWine faces a test of the far right’s sway as he seeks another term in office
7:46AM ( 48 minutes ago )
Report: Supreme Court draft suggests Roe could be overturned
A draft opinion suggests the U.S. Supreme Court could be poised to overturn the landmark 1973 Roe v
7:44AM ( 50 minutes ago )